Business · 23/10/20261 min read
Rakuten Medical Presents Long-Term Follow-up Results of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for R/M HNSCC at ESMO 2026
Summary
The source item contains limited metadata.
Original source language: PR Newswire — Global News ReleasesOpen original release →